Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer
NCT00502164 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2011-01-21
Summary
A study to assess safety and tolerability of AZD2171 after multiple doses in patients with advanced prostate cancer.
Conditions
- Advanced Prostate Adenocarcinoma
Interventions
- DRUG
-
AZD2171
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Nick Botwood, BSc, MBBS, MRCP, MFPM · AstraZeneca
-
Eric Small, MD · University of California, San Francisco
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-03-31
Countries
- United States
Study Locations
More Related Trials
-
AZD2171 to Treat Prostate Cancer
NCT00436956 ·Status: COMPLETED ·Phase: PHASE2
-
AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer
NCT00519233 ·Status: COMPLETED ·Phase: PHASE1
-
Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers
NCT00223171 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer
NCT04089553 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer
NCT02064608 ·Status: COMPLETED ·Phase: PHASE1
-
ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00471718 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00527124 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis
NCT00241111 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I/II Study of HE3235 in Patients With Prostate Cancer
NCT00716794 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer
NCT00286806 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
NCT05800665 ·Status: RECRUITING ·Phase: PHASE1
-
AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00513071 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer
NCT03458247 ·Status: COMPLETED ·Phase: PHASE2
-
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
NCT00134056 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases
NCT00242554 ·Status: COMPLETED ·Phase: PHASE4
-
Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer
NCT00219271 ·Status: COMPLETED ·Phase: PHASE4
-
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
NCT00111618 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy
NCT02121639 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
NCT04446117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
NCT00503984 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
NCT00510718 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Study of AZD5069 and Enzalutamide.
NCT03177187 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients
NCT01352208 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy
NCT00172055 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
NCT07192614 ·Status: RECRUITING ·Phase: PHASE1/PHASE2